Unit
- Managed care pharmacy: A system of pharmaceutical care that integrates financing, utilization management, and clinical oversight to ensure cost-effective medication use within a defined patient population. It emerged in the 1980s as a response to rising drug costs and fragmented care.
- Historical origins: Early health maintenance organizations (HMOs) and the creation of pharmacy benefit managers (PBMs) in the 1960s-1970s laid the groundwork. The first PBM, Prescription Services Inc., was founded in 1969, followed by expansions of formularies and drug utilization review programs.
- Evolution of formularies: Closed formularies replaced open formularies to restrict non-preferred drugs. By the 1990s, tiered formularies emerged, aligning patient copays with drug cost tiers to influence prescribing and consumption patterns.
- Drug utilization review: Prospective, concurrent, and retrospective DUR became standard to identify inappropriate prescribing, drug interactions, and adherence gaps. DUR is a cornerstone of quality improvement in managed care.
- Impact of generic drugs: The Hatch-Waxman Act of 1984 accelerated generic drug entry, enabling PBMs and plans to achieve significant cost savings through generic substitution and therapeutic interchange programs.
- Specialty pharmacy growth: Biologics and high-cost specialty drugs drove the need for specialized management. Managed care organizations developed dedicated specialty pharmacy subsidiaries to control costs and ensure patient adherence.
- Consumer-directed health plans: High-deductible plans and health savings accounts shifted cost responsibility to consumers. Managed care pharmacy responded with tools like medication price transparency and step therapy to guide consumer choices.
- Value-based contracting: Recent models tie drug reimbursement to clinical outcomes. Outcomes-based contracts and indication-based pricing are emerging strategies to align payments with patient value.
- Population health management: Managed care pharmacists analyze aggregated data to identify at-risk patient groups, design targeted interventions such as medication synchronization or adherence programs, and monitor population-level outcomes like hospital readmission rates. This proactive approach uses predictive analytics to allocate resources efficiently and improve overall health within the covered population.
- Medication therapy management: MTM programs are offered to patients with multiple chronic conditions or high drug costs. Pharmacists conduct comprehensive medication reviews, identify duplications or gaps, and collaborate with prescribers to optimize therapy. In managed care, MTM is often delivered telephonically and is tied to quality metrics like Star Ratings for Medicare plans.
- Pharmacoeconomics and outcomes research: Managed care pharmacists apply cost-effectiveness analysis, budget impact models, and comparative effectiveness research to inform formulary decisions. They evaluate real-world evidence from claims data to assess the clinical and economic value of new therapies, ensuring that coverage policies align with both patient benefits and plan sustainability.
Scope of Practice
Role: Managed Care Pharmacist (PBM Setting)
Within scope:
- Developing and maintaining drug formularies based on clinical evidence.
- Conducting drug utilization reviews to identify inappropriate prescribing patterns.
- Designing prior authorization criteria and step therapy protocols.
- Negotiating rebate contracts with pharmaceutical manufacturers.
- Providing clinical support to member services and case management teams.
Outside scope:
- Dispensing medications directly to patients.
- Providing face-to-face medication therapy management in retail settings.
- Diagnosing medical conditions or prescribing medications.
- Managing acute clinical emergencies.
- Operating pharmacy inventory in a community pharmacy.
Quick Revision
- Managed care pharmacy is a system integrating financing and clinical oversight for cost-effective medication use.
- Evolved from early HMOs and PBM models in the 1980s.
- Open formularies, prior authorization, and DUR are key tools.
- Managed care pharmacists focus on population-level clinical and financial outcomes.